Michael Garrison compensation by year
BECTON DICKINSON Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $675,000 | $731,250 | $768,750 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $1,284,490 | $1,513,105 | $1,641,596 |
| Option awards | $547,135 | $653,450 | $544,118 |
| Non-equity incentive | $599,569 | $556,200 | $533,588 |
| Pension and deferred compensation | $93,911 | $122,852 | $102,800 |
| All other | $454,263 | $45,225 | $58,188 |
| Total | $3,654,368 | $3,622,082 | $3,649,040 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BECTON DICKINSON & CO DEF 14A filed December 18, 2025, accession 0001628280-25-057846, and prior-year filings. Open the filing on EDGAR.
How this page was built: the BECTON DICKINSON & CO filed document, accession 0001628280-25-057846. Every figure is read from that document and cited to the page and table it appears in. Filed December 18, 2025.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 19,832 | $3,711,955 | — |
| RSU | 7,371 | $1,379,630 | — |
| Option | 10,004 | — | $224.25 |
| Option | 7,773 | — | $238.89 |
| Option | 4,734 | — | $238.06 |
| Option | 1,992 | — | $241.10 |
Per the Outstanding Equity Awards at Fiscal Year-End table in BECTON DICKINSON & CO's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
BECTON DICKINSON’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Thomas Polen | Chairman, Chief Executive Officer and President | $17,129,140 |
| Christopher DelOrefice | Executive Vice President and Chief Financial Officer | $5,877,164 |
| Michael Feld | Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment | $4,096,356 |
| Michael Garrison · this page | Executive Vice President and President, Medical Essentials and BioPharma Systems Segments | $3,649,040 |
| Richard Byrd | Executive Vice President and President, Interventional Segment | $3,399,056 |
Michael Garrison's compensation dossier, BECTON DICKINSON
You have read Michael Garrison's totals and holdings. The dossier adds each equity grant BECTON DICKINSON disclosed for Michael Garrison and BECTON DICKINSON's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full BECTON DICKINSON compensation record
free company briefThis page is one person within BECTON DICKINSON's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the BECTON DICKINSON proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BECTON DICKINSON's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BECTON DICKINSON's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order BDX
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.